nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Topotecan—peripheral nervous system neoplasm	0.326	1	CrCtD
Irinotecan—Topoisomerase Inhibitors—Topotecan—peripheral nervous system neoplasm	0.139	0.392	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Etoposide—peripheral nervous system neoplasm	0.0928	0.262	CiPCiCtD
Irinotecan—BCHE—peripheral nervous system neoplasm	0.0676	0.718	CbGaD
Irinotecan—TOP1MT—Topotecan—peripheral nervous system neoplasm	0.0669	0.375	CbGbCtD
Irinotecan—Topoisomerase Inhibitors—Epirubicin—peripheral nervous system neoplasm	0.0639	0.18	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Doxorubicin—peripheral nervous system neoplasm	0.0591	0.167	CiPCiCtD
Irinotecan—TOP1—Topotecan—peripheral nervous system neoplasm	0.0384	0.216	CbGbCtD
Irinotecan—ABCB1—peripheral nervous system neoplasm	0.0265	0.281	CbGaD
Irinotecan—SLC22A3—Melphalan—peripheral nervous system neoplasm	0.012	0.0675	CbGbCtD
Irinotecan—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.00378	0.0212	CbGbCtD
Irinotecan—ABCG2—Topotecan—peripheral nervous system neoplasm	0.00365	0.0204	CbGbCtD
Irinotecan—SLC22A3—Vincristine—peripheral nervous system neoplasm	0.00356	0.02	CbGbCtD
Irinotecan—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.00274	0.0153	CbGbCtD
Irinotecan—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.00259	0.0145	CbGbCtD
Irinotecan—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.00253	0.0142	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0025	0.014	CbGbCtD
Irinotecan—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0025	0.014	CbGbCtD
Irinotecan—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.00238	0.0134	CbGbCtD
Irinotecan—ABCC1—Vincristine—peripheral nervous system neoplasm	0.00233	0.013	CbGbCtD
Irinotecan—ABCC1—Etoposide—peripheral nervous system neoplasm	0.00213	0.0119	CbGbCtD
Irinotecan—BCHE—Cisplatin—peripheral nervous system neoplasm	0.00206	0.0116	CbGbCtD
Irinotecan—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.00188	0.0105	CbGbCtD
Irinotecan—ABCC2—Vincristine—peripheral nervous system neoplasm	0.00172	0.00965	CbGbCtD
Irinotecan—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.00161	0.009	CbGbCtD
Irinotecan—ABCC2—Etoposide—peripheral nervous system neoplasm	0.00158	0.00884	CbGbCtD
Irinotecan—ABCG2—Vincristine—peripheral nervous system neoplasm	0.00156	0.00872	CbGbCtD
Irinotecan—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.00145	0.00815	CbGbCtD
Irinotecan—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.00145	0.00814	CbGbCtD
Irinotecan—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00143	0.00799	CbGbCtD
Irinotecan—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00737	CbGbCtD
Irinotecan—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00131	0.00737	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.00115	0.00644	CbGbCtD
Irinotecan—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.00115	0.00644	CbGbCtD
Irinotecan—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00603	CbGbCtD
Irinotecan—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00572	CbGbCtD
Irinotecan—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.000973	0.00545	CbGbCtD
Irinotecan—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.000911	0.00511	CbGbCtD
Irinotecan—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.000862	0.00483	CbGbCtD
Irinotecan—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00079	0.00443	CbGbCtD
Irinotecan—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.000788	0.00442	CbGbCtD
Irinotecan—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.000732	0.00411	CbGbCtD
Irinotecan—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.000684	0.00384	CbGbCtD
Irinotecan—ABCB1—Vincristine—peripheral nervous system neoplasm	0.000561	0.00315	CbGbCtD
Irinotecan—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.000523	0.00293	CbGbCtD
Irinotecan—ABCB1—Etoposide—peripheral nervous system neoplasm	0.000514	0.00288	CbGbCtD
Irinotecan—Topotecan—ABCB1—peripheral nervous system neoplasm	0.000489	1	CrCbGaD
Irinotecan—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.00197	CbGbCtD
Irinotecan—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.000336	0.00188	CbGbCtD
Irinotecan—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.000308	0.00173	CbGbCtD
Irinotecan—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.00118	CbGbCtD
Irinotecan—Rash—Tretinoin—peripheral nervous system neoplasm	2.02e-05	0.000544	CcSEcCtD
Irinotecan—Rash—Isotretinoin—peripheral nervous system neoplasm	2.02e-05	0.000544	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	2.02e-05	0.000544	CcSEcCtD
Irinotecan—Dermatitis—Tretinoin—peripheral nervous system neoplasm	2.02e-05	0.000543	CcSEcCtD
Irinotecan—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	2.02e-05	0.000543	CcSEcCtD
Irinotecan—Fatigue—Vincristine—peripheral nervous system neoplasm	2.02e-05	0.000543	CcSEcCtD
Irinotecan—Vomiting—Melphalan—peripheral nervous system neoplasm	2.01e-05	0.000541	CcSEcCtD
Irinotecan—Dehydration—Epirubicin—peripheral nervous system neoplasm	2.01e-05	0.000541	CcSEcCtD
Irinotecan—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	2.01e-05	0.000541	CcSEcCtD
Irinotecan—Headache—Tretinoin—peripheral nervous system neoplasm	2.01e-05	0.00054	CcSEcCtD
Irinotecan—Headache—Isotretinoin—peripheral nervous system neoplasm	2.01e-05	0.00054	CcSEcCtD
Irinotecan—Hypertension—Etoposide—peripheral nervous system neoplasm	2.01e-05	0.00054	CcSEcCtD
Irinotecan—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	2e-05	0.000539	CcSEcCtD
Irinotecan—Pain—Vincristine—peripheral nervous system neoplasm	2e-05	0.000539	CcSEcCtD
Irinotecan—Constipation—Vincristine—peripheral nervous system neoplasm	2e-05	0.000539	CcSEcCtD
Irinotecan—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	2e-05	0.000538	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	2e-05	0.000538	CcSEcCtD
Irinotecan—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	2e-05	0.000538	CcSEcCtD
Irinotecan—Rash—Melphalan—peripheral nervous system neoplasm	2e-05	0.000537	CcSEcCtD
Irinotecan—Dermatitis—Melphalan—peripheral nervous system neoplasm	1.99e-05	0.000536	CcSEcCtD
Irinotecan—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	1.99e-05	0.000534	CcSEcCtD
Irinotecan—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	1.98e-05	0.000531	CcSEcCtD
Irinotecan—Anorexia—Cisplatin—peripheral nervous system neoplasm	1.97e-05	0.000531	CcSEcCtD
Irinotecan—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	1.97e-05	0.00053	CcSEcCtD
Irinotecan—Discomfort—Etoposide—peripheral nervous system neoplasm	1.96e-05	0.000526	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	1.95e-05	0.000524	CcSEcCtD
Irinotecan—Hypotension—Cisplatin—peripheral nervous system neoplasm	1.94e-05	0.00052	CcSEcCtD
Irinotecan—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	1.93e-05	0.000519	CcSEcCtD
Irinotecan—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	1.92e-05	0.000517	CcSEcCtD
Irinotecan—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	1.92e-05	0.000517	CcSEcCtD
Irinotecan—Nausea—Topotecan—peripheral nervous system neoplasm	1.92e-05	0.000516	CcSEcCtD
Irinotecan—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	1.92e-05	0.000515	CcSEcCtD
Irinotecan—Confusional state—Etoposide—peripheral nervous system neoplasm	1.91e-05	0.000514	CcSEcCtD
Irinotecan—Nausea—Isotretinoin—peripheral nervous system neoplasm	1.91e-05	0.000512	CcSEcCtD
Irinotecan—Nausea—Tretinoin—peripheral nervous system neoplasm	1.91e-05	0.000512	CcSEcCtD
Irinotecan—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	1.9e-05	0.000512	CcSEcCtD
Irinotecan—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	1.9e-05	0.00051	CcSEcCtD
Irinotecan—Infection—Etoposide—peripheral nervous system neoplasm	1.89e-05	0.000507	CcSEcCtD
Irinotecan—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	1.88e-05	0.000506	CcSEcCtD
Irinotecan—Asthenia—Dactinomycin—peripheral nervous system neoplasm	1.88e-05	0.000506	CcSEcCtD
Irinotecan—Nausea—Melphalan—peripheral nervous system neoplasm	1.88e-05	0.000506	CcSEcCtD
Irinotecan—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	1.88e-05	0.000504	CcSEcCtD
Irinotecan—Dehydration—Doxorubicin—peripheral nervous system neoplasm	1.86e-05	0.000501	CcSEcCtD
Irinotecan—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	1.86e-05	0.0005	CcSEcCtD
Irinotecan—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	1.86e-05	0.0005	CcSEcCtD
Irinotecan—Body temperature increased—Vincristine—peripheral nervous system neoplasm	1.85e-05	0.000498	CcSEcCtD
Irinotecan—Abdominal pain—Vincristine—peripheral nervous system neoplasm	1.85e-05	0.000498	CcSEcCtD
Irinotecan—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	1.85e-05	0.000496	CcSEcCtD
Irinotecan—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	1.83e-05	0.000493	CcSEcCtD
Irinotecan—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	1.83e-05	0.000493	CcSEcCtD
Irinotecan—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	1.83e-05	0.000492	CcSEcCtD
Irinotecan—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	1.82e-05	0.00049	CcSEcCtD
Irinotecan—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	1.82e-05	0.00049	CcSEcCtD
Irinotecan—Anorexia—Etoposide—peripheral nervous system neoplasm	1.81e-05	0.000486	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	1.8e-05	0.000485	CcSEcCtD
Irinotecan—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	1.8e-05	0.000484	CcSEcCtD
Irinotecan—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	1.79e-05	0.000482	CcSEcCtD
Irinotecan—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	1.79e-05	0.000482	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	1.79e-05	0.000481	CcSEcCtD
Irinotecan—Hypotension—Etoposide—peripheral nervous system neoplasm	1.77e-05	0.000477	CcSEcCtD
Irinotecan—Pain—Cisplatin—peripheral nervous system neoplasm	1.77e-05	0.000476	CcSEcCtD
Irinotecan—Neutropenia—Epirubicin—peripheral nervous system neoplasm	1.75e-05	0.00047	CcSEcCtD
Irinotecan—Asthenia—Alitretinoin—peripheral nervous system neoplasm	1.74e-05	0.000469	CcSEcCtD
Irinotecan—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	0.000468	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	1.74e-05	0.000467	CcSEcCtD
Irinotecan—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	1.73e-05	0.000464	CcSEcCtD
Irinotecan—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	1.71e-05	0.000459	CcSEcCtD
Irinotecan—Paraesthesia—Etoposide—peripheral nervous system neoplasm	1.7e-05	0.000458	CcSEcCtD
Irinotecan—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	1.7e-05	0.000456	CcSEcCtD
Irinotecan—Weight decreased—Epirubicin—peripheral nervous system neoplasm	1.69e-05	0.000455	CcSEcCtD
Irinotecan—Dyspnoea—Etoposide—peripheral nervous system neoplasm	1.69e-05	0.000455	CcSEcCtD
Irinotecan—Somnolence—Etoposide—peripheral nervous system neoplasm	1.69e-05	0.000454	CcSEcCtD
Irinotecan—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	1.69e-05	0.000453	CcSEcCtD
Irinotecan—Asthenia—Vincristine—peripheral nervous system neoplasm	1.68e-05	0.000452	CcSEcCtD
Irinotecan—Pneumonia—Epirubicin—peripheral nervous system neoplasm	1.68e-05	0.000451	CcSEcCtD
Irinotecan—Vomiting—Dactinomycin—peripheral nervous system neoplasm	1.67e-05	0.000448	CcSEcCtD
Irinotecan—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	1.66e-05	0.000447	CcSEcCtD
Irinotecan—Rash—Dactinomycin—peripheral nervous system neoplasm	1.65e-05	0.000444	CcSEcCtD
Irinotecan—Decreased appetite—Etoposide—peripheral nervous system neoplasm	1.65e-05	0.000444	CcSEcCtD
Irinotecan—Renal failure—Epirubicin—peripheral nervous system neoplasm	1.64e-05	0.000441	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	1.64e-05	0.00044	CcSEcCtD
Irinotecan—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	1.64e-05	0.00044	CcSEcCtD
Irinotecan—Fatigue—Etoposide—peripheral nervous system neoplasm	1.64e-05	0.00044	CcSEcCtD
Irinotecan—Jaundice—Epirubicin—peripheral nervous system neoplasm	1.63e-05	0.000437	CcSEcCtD
Irinotecan—Stomatitis—Epirubicin—peripheral nervous system neoplasm	1.63e-05	0.000437	CcSEcCtD
Irinotecan—Pain—Etoposide—peripheral nervous system neoplasm	1.62e-05	0.000436	CcSEcCtD
Irinotecan—Constipation—Etoposide—peripheral nervous system neoplasm	1.62e-05	0.000436	CcSEcCtD
Irinotecan—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	1.62e-05	0.000435	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	1.61e-05	0.000432	CcSEcCtD
Irinotecan—Dizziness—Alitretinoin—peripheral nervous system neoplasm	1.61e-05	0.000432	CcSEcCtD
Irinotecan—Diarrhoea—Vincristine—peripheral nervous system neoplasm	1.6e-05	0.000431	CcSEcCtD
Irinotecan—Sweating—Epirubicin—peripheral nervous system neoplasm	1.6e-05	0.00043	CcSEcCtD
Irinotecan—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	1.57e-05	0.000421	CcSEcCtD
Irinotecan—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	1.56e-05	0.00042	CcSEcCtD
Irinotecan—Nausea—Dactinomycin—peripheral nervous system neoplasm	1.56e-05	0.000419	CcSEcCtD
Irinotecan—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	1.55e-05	0.000417	CcSEcCtD
Irinotecan—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	1.55e-05	0.000417	CcSEcCtD
Irinotecan—Dizziness—Vincristine—peripheral nervous system neoplasm	1.55e-05	0.000416	CcSEcCtD
Irinotecan—Vomiting—Alitretinoin—peripheral nervous system neoplasm	1.55e-05	0.000416	CcSEcCtD
Irinotecan—Rash—Alitretinoin—peripheral nervous system neoplasm	1.53e-05	0.000412	CcSEcCtD
Irinotecan—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	1.53e-05	0.000412	CcSEcCtD
Irinotecan—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	1.53e-05	0.00041	CcSEcCtD
Irinotecan—Bradycardia—Epirubicin—peripheral nervous system neoplasm	1.52e-05	0.00041	CcSEcCtD
Irinotecan—Headache—Alitretinoin—peripheral nervous system neoplasm	1.52e-05	0.000409	CcSEcCtD
Irinotecan—Renal failure—Doxorubicin—peripheral nervous system neoplasm	1.52e-05	0.000408	CcSEcCtD
Irinotecan—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	1.51e-05	0.000405	CcSEcCtD
Irinotecan—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	1.5e-05	0.000404	CcSEcCtD
Irinotecan—Jaundice—Doxorubicin—peripheral nervous system neoplasm	1.5e-05	0.000404	CcSEcCtD
Irinotecan—Rhinitis—Epirubicin—peripheral nervous system neoplasm	1.5e-05	0.000404	CcSEcCtD
Irinotecan—Abdominal pain—Etoposide—peripheral nervous system neoplasm	1.5e-05	0.000403	CcSEcCtD
Irinotecan—Body temperature increased—Etoposide—peripheral nervous system neoplasm	1.5e-05	0.000403	CcSEcCtD
Irinotecan—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	1.5e-05	0.000403	CcSEcCtD
Irinotecan—Vomiting—Vincristine—peripheral nervous system neoplasm	1.49e-05	0.0004	CcSEcCtD
Irinotecan—Asthenia—Cisplatin—peripheral nervous system neoplasm	1.49e-05	0.0004	CcSEcCtD
Irinotecan—Sweating—Doxorubicin—peripheral nervous system neoplasm	1.48e-05	0.000398	CcSEcCtD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	1.48e-05	0.0017	CbGpPWpGaD
Irinotecan—Rash—Vincristine—peripheral nervous system neoplasm	1.48e-05	0.000397	CcSEcCtD
Irinotecan—Dermatitis—Vincristine—peripheral nervous system neoplasm	1.48e-05	0.000397	CcSEcCtD
Irinotecan—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	1.47e-05	0.000396	CcSEcCtD
Irinotecan—Headache—Vincristine—peripheral nervous system neoplasm	1.47e-05	0.000395	CcSEcCtD
Irinotecan—ACHE—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.46e-05	0.00168	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—BCHE—peripheral nervous system neoplasm	1.45e-05	0.00167	CbGpPWpGaD
Irinotecan—Nausea—Alitretinoin—peripheral nervous system neoplasm	1.44e-05	0.000388	CcSEcCtD
Irinotecan—Visual impairment—Epirubicin—peripheral nervous system neoplasm	1.44e-05	0.000388	CcSEcCtD
Irinotecan—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	1.43e-05	0.00164	CbGpPWpGaD
Irinotecan—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	1.42e-05	0.000381	CcSEcCtD
Irinotecan—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	1.41e-05	0.000379	CcSEcCtD
Irinotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	1.4e-05	0.00161	CbGpPWpGaD
Irinotecan—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	1.4e-05	0.000376	CcSEcCtD
Irinotecan—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	1.39e-05	0.000374	CcSEcCtD
Irinotecan—Nausea—Vincristine—peripheral nervous system neoplasm	1.39e-05	0.000374	CcSEcCtD
Irinotecan—Flushing—Epirubicin—peripheral nervous system neoplasm	1.39e-05	0.000374	CcSEcCtD
Irinotecan—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	1.39e-05	0.000374	CcSEcCtD
Irinotecan—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	1.39e-05	0.000373	CcSEcCtD
Irinotecan—UGT1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.39e-05	0.00159	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.39e-05	0.00159	CbGpPWpGaD
Irinotecan—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	1.39e-05	0.000372	CcSEcCtD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	1.36e-05	0.00157	CbGpPWpGaD
Irinotecan—Asthenia—Etoposide—peripheral nervous system neoplasm	1.36e-05	0.000366	CcSEcCtD
Irinotecan—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	1.36e-05	0.000366	CcSEcCtD
Irinotecan—Angiopathy—Epirubicin—peripheral nervous system neoplasm	1.36e-05	0.000365	CcSEcCtD
Irinotecan—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	1.35e-05	0.000364	CcSEcCtD
Irinotecan—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	1.35e-05	0.000363	CcSEcCtD
Irinotecan—Chills—Epirubicin—peripheral nervous system neoplasm	1.34e-05	0.000361	CcSEcCtD
Irinotecan—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	1.34e-05	0.00036	CcSEcCtD
Irinotecan—ABCC1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.34e-05	0.00154	CbGpPWpGaD
Irinotecan—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	1.34e-05	0.000359	CcSEcCtD
Irinotecan—Alopecia—Epirubicin—peripheral nervous system neoplasm	1.32e-05	0.000356	CcSEcCtD
Irinotecan—Vomiting—Cisplatin—peripheral nervous system neoplasm	1.32e-05	0.000354	CcSEcCtD
Irinotecan—Rash—Cisplatin—peripheral nervous system neoplasm	1.31e-05	0.000351	CcSEcCtD
Irinotecan—Dermatitis—Cisplatin—peripheral nervous system neoplasm	1.31e-05	0.000351	CcSEcCtD
Irinotecan—BCHE—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.3e-05	0.0015	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.3e-05	0.00149	CbGpPWpGaD
Irinotecan—Diarrhoea—Etoposide—peripheral nervous system neoplasm	1.3e-05	0.000349	CcSEcCtD
Irinotecan—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	1.29e-05	0.000346	CcSEcCtD
Irinotecan—Flushing—Doxorubicin—peripheral nervous system neoplasm	1.29e-05	0.000346	CcSEcCtD
Irinotecan—ABCC1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.29e-05	0.00148	CbGpPWpGaD
Irinotecan—Flatulence—Epirubicin—peripheral nervous system neoplasm	1.28e-05	0.000345	CcSEcCtD
Irinotecan—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	1.27e-05	0.00146	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.27e-05	0.00146	CbGpPWpGaD
Irinotecan—Back pain—Epirubicin—peripheral nervous system neoplasm	1.26e-05	0.000339	CcSEcCtD
Irinotecan—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	1.26e-05	0.000338	CcSEcCtD
Irinotecan—Dizziness—Etoposide—peripheral nervous system neoplasm	1.26e-05	0.000337	CcSEcCtD
Irinotecan—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	1.25e-05	0.000337	CcSEcCtD
Irinotecan—SLC22A3—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.25e-05	0.00144	CbGpPWpGaD
Irinotecan—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	1.25e-05	0.000336	CcSEcCtD
Irinotecan—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	1.25e-05	0.000336	CcSEcCtD
Irinotecan—Chills—Doxorubicin—peripheral nervous system neoplasm	1.24e-05	0.000334	CcSEcCtD
Irinotecan—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	1.24e-05	0.000333	CcSEcCtD
Irinotecan—Nausea—Cisplatin—peripheral nervous system neoplasm	1.23e-05	0.000331	CcSEcCtD
Irinotecan—Alopecia—Doxorubicin—peripheral nervous system neoplasm	1.22e-05	0.000329	CcSEcCtD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.22e-05	0.0014	CbGpPWpGaD
Irinotecan—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	1.21e-05	0.000325	CcSEcCtD
Irinotecan—Vomiting—Etoposide—peripheral nervous system neoplasm	1.21e-05	0.000324	CcSEcCtD
Irinotecan—Anaemia—Epirubicin—peripheral nervous system neoplasm	1.2e-05	0.000324	CcSEcCtD
Irinotecan—Rash—Etoposide—peripheral nervous system neoplasm	1.2e-05	0.000322	CcSEcCtD
Irinotecan—Dermatitis—Etoposide—peripheral nervous system neoplasm	1.2e-05	0.000321	CcSEcCtD
Irinotecan—Headache—Etoposide—peripheral nervous system neoplasm	1.19e-05	0.00032	CcSEcCtD
Irinotecan—Flatulence—Doxorubicin—peripheral nervous system neoplasm	1.19e-05	0.000319	CcSEcCtD
Irinotecan—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.18e-05	0.00135	CbGpPWpGaD
Irinotecan—Malaise—Epirubicin—peripheral nervous system neoplasm	1.18e-05	0.000316	CcSEcCtD
Irinotecan—Vertigo—Epirubicin—peripheral nervous system neoplasm	1.17e-05	0.000315	CcSEcCtD
Irinotecan—Syncope—Epirubicin—peripheral nervous system neoplasm	1.17e-05	0.000314	CcSEcCtD
Irinotecan—Leukopenia—Epirubicin—peripheral nervous system neoplasm	1.17e-05	0.000314	CcSEcCtD
Irinotecan—Back pain—Doxorubicin—peripheral nervous system neoplasm	1.17e-05	0.000314	CcSEcCtD
Irinotecan—CYP3A7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.17e-05	0.00134	CbGpPWpGaD
Irinotecan—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	1.16e-05	0.000312	CcSEcCtD
Irinotecan—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	1.15e-05	0.000308	CcSEcCtD
Irinotecan—Cough—Epirubicin—peripheral nervous system neoplasm	1.14e-05	0.000306	CcSEcCtD
Irinotecan—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.13e-05	0.0013	CbGpPWpGaD
Irinotecan—Nausea—Etoposide—peripheral nervous system neoplasm	1.13e-05	0.000303	CcSEcCtD
Irinotecan—Hypertension—Epirubicin—peripheral nervous system neoplasm	1.13e-05	0.000303	CcSEcCtD
Irinotecan—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	1.12e-05	0.000301	CcSEcCtD
Irinotecan—Anaemia—Doxorubicin—peripheral nervous system neoplasm	1.11e-05	0.0003	CcSEcCtD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.1e-05	0.00126	CbGpPWpGaD
Irinotecan—Discomfort—Epirubicin—peripheral nervous system neoplasm	1.1e-05	0.000295	CcSEcCtD
Irinotecan—Malaise—Doxorubicin—peripheral nervous system neoplasm	1.09e-05	0.000292	CcSEcCtD
Irinotecan—Vertigo—Doxorubicin—peripheral nervous system neoplasm	1.08e-05	0.000291	CcSEcCtD
Irinotecan—Syncope—Doxorubicin—peripheral nervous system neoplasm	1.08e-05	0.000291	CcSEcCtD
Irinotecan—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	1.08e-05	0.00029	CcSEcCtD
Irinotecan—Confusional state—Epirubicin—peripheral nervous system neoplasm	1.07e-05	0.000288	CcSEcCtD
Irinotecan—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	1.06e-05	0.000286	CcSEcCtD
Irinotecan—Oedema—Epirubicin—peripheral nervous system neoplasm	1.06e-05	0.000286	CcSEcCtD
Irinotecan—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	1.06e-05	0.000285	CcSEcCtD
Irinotecan—Infection—Epirubicin—peripheral nervous system neoplasm	1.06e-05	0.000284	CcSEcCtD
Irinotecan—Cough—Doxorubicin—peripheral nervous system neoplasm	1.05e-05	0.000283	CcSEcCtD
Irinotecan—Shock—Epirubicin—peripheral nervous system neoplasm	1.05e-05	0.000281	CcSEcCtD
Irinotecan—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	1.04e-05	0.00028	CcSEcCtD
Irinotecan—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	1.04e-05	0.00028	CcSEcCtD
Irinotecan—Hypertension—Doxorubicin—peripheral nervous system neoplasm	1.04e-05	0.00028	CcSEcCtD
Irinotecan—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	1.03e-05	0.000276	CcSEcCtD
Irinotecan—Discomfort—Doxorubicin—peripheral nervous system neoplasm	1.01e-05	0.000273	CcSEcCtD
Irinotecan—Anorexia—Epirubicin—peripheral nervous system neoplasm	1.01e-05	0.000273	CcSEcCtD
Irinotecan—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.94e-06	0.000267	CcSEcCtD
Irinotecan—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.93e-06	0.000267	CcSEcCtD
Irinotecan—ACHE—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.87e-06	0.00113	CbGpPWpGaD
Irinotecan—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.84e-06	0.000265	CcSEcCtD
Irinotecan—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.84e-06	0.000265	CcSEcCtD
Irinotecan—Infection—Doxorubicin—peripheral nervous system neoplasm	9.78e-06	0.000263	CcSEcCtD
Irinotecan—Shock—Doxorubicin—peripheral nervous system neoplasm	9.69e-06	0.00026	CcSEcCtD
Irinotecan—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.65e-06	0.00026	CcSEcCtD
Irinotecan—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	9.64e-06	0.000259	CcSEcCtD
Irinotecan—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.62e-06	0.000259	CcSEcCtD
Irinotecan—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.55e-06	0.000257	CcSEcCtD
Irinotecan—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	9.52e-06	0.000256	CcSEcCtD
Irinotecan—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	9.49e-06	0.000255	CcSEcCtD
Irinotecan—Somnolence—Epirubicin—peripheral nervous system neoplasm	9.46e-06	0.000254	CcSEcCtD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	9.45e-06	0.00109	CbGpPWpGaD
Irinotecan—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.38e-06	0.000252	CcSEcCtD
Irinotecan—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	9.37e-06	0.000252	CcSEcCtD
Irinotecan—UGT1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.36e-06	0.00108	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.36e-06	0.00108	CbGpPWpGaD
Irinotecan—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	9.25e-06	0.000249	CcSEcCtD
Irinotecan—Hypotension—Doxorubicin—peripheral nervous system neoplasm	9.2e-06	0.000247	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.19e-06	0.000247	CcSEcCtD
Irinotecan—Fatigue—Epirubicin—peripheral nervous system neoplasm	9.17e-06	0.000247	CcSEcCtD
Irinotecan—Pain—Epirubicin—peripheral nervous system neoplasm	9.1e-06	0.000245	CcSEcCtD
Irinotecan—Constipation—Epirubicin—peripheral nervous system neoplasm	9.1e-06	0.000245	CcSEcCtD
Irinotecan—SLC22A3—Metabolism—GNS—peripheral nervous system neoplasm	9.06e-06	0.00104	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.03e-06	0.00104	CbGpPWpGaD
Irinotecan—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.9e-06	0.000239	CcSEcCtD
Irinotecan—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.84e-06	0.000238	CcSEcCtD
Irinotecan—BCHE—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.8e-06	0.00101	CbGpPWpGaD
Irinotecan—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.78e-06	0.000236	CcSEcCtD
Irinotecan—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.77e-06	0.000236	CcSEcCtD
Irinotecan—Somnolence—Doxorubicin—peripheral nervous system neoplasm	8.75e-06	0.000235	CcSEcCtD
Irinotecan—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.7e-06	0.000234	CcSEcCtD
Irinotecan—SLC22A3—Metabolism—NME1—peripheral nervous system neoplasm	8.69e-06	0.000998	CbGpPWpGaD
Irinotecan—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.67e-06	0.000233	CcSEcCtD
Irinotecan—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.62e-06	0.00099	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.58e-06	0.000986	CbGpPWpGaD
Irinotecan—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.56e-06	0.00023	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.5e-06	0.000228	CcSEcCtD
Irinotecan—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.49e-06	0.000228	CcSEcCtD
Irinotecan—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.42e-06	0.000968	CbGpPWpGaD
Irinotecan—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.42e-06	0.000226	CcSEcCtD
Irinotecan—Pain—Doxorubicin—peripheral nervous system neoplasm	8.42e-06	0.000226	CcSEcCtD
Irinotecan—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.41e-06	0.000226	CcSEcCtD
Irinotecan—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.41e-06	0.000226	CcSEcCtD
Irinotecan—SLC22A3—Metabolism—COX2—peripheral nervous system neoplasm	8.36e-06	0.000961	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	8.28e-06	0.000951	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.2e-06	0.000942	CbGpPWpGaD
Irinotecan—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.11e-06	0.000218	CcSEcCtD
Irinotecan—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.05e-06	0.000216	CcSEcCtD
Irinotecan—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.94e-06	0.000913	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.87e-06	0.000905	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	7.84e-06	0.000901	CbGpPWpGaD
Irinotecan—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.84e-06	0.000211	CcSEcCtD
Irinotecan—ABCC1—Disease—GNS—peripheral nervous system neoplasm	7.79e-06	0.000895	CbGpPWpGaD
Irinotecan—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.78e-06	0.000209	CcSEcCtD
Irinotecan—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.78e-06	0.000209	CcSEcCtD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.78e-06	0.000894	CbGpPWpGaD
Irinotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	7.66e-06	0.00088	CbGpPWpGaD
Irinotecan—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.63e-06	0.000205	CcSEcCtD
Irinotecan—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	7.62e-06	0.000875	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.6e-06	0.000873	CbGpPWpGaD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	7.58e-06	0.000871	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	7.51e-06	0.000863	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.5e-06	0.000862	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.46e-06	0.000857	CbGpPWpGaD
Irinotecan—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.28e-06	0.000196	CcSEcCtD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	7.27e-06	0.000835	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.26e-06	0.000834	CbGpPWpGaD
Irinotecan—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.25e-06	0.000195	CcSEcCtD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	7.15e-06	0.000821	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GNS—peripheral nervous system neoplasm	7.13e-06	0.00082	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.13e-06	0.000819	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	7.08e-06	0.000814	CbGpPWpGaD
Irinotecan—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.06e-06	0.00019	CcSEcCtD
Irinotecan—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.04e-06	0.000189	CcSEcCtD
Irinotecan—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.98e-06	0.000802	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.89e-06	0.000791	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—NME1—peripheral nervous system neoplasm	6.84e-06	0.000786	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.8e-06	0.000782	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GNS—peripheral nervous system neoplasm	6.77e-06	0.000778	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GNS—peripheral nervous system neoplasm	6.77e-06	0.000778	CbGpPWpGaD
Irinotecan—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.76e-06	0.000182	CcSEcCtD
Irinotecan—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.74e-06	0.000181	CcSEcCtD
Irinotecan—Rash—Epirubicin—peripheral nervous system neoplasm	6.71e-06	0.00018	CcSEcCtD
Irinotecan—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.7e-06	0.00018	CcSEcCtD
Irinotecan—Headache—Epirubicin—peripheral nervous system neoplasm	6.67e-06	0.000179	CcSEcCtD
Irinotecan—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	6.63e-06	0.000761	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—COX2—peripheral nervous system neoplasm	6.58e-06	0.000756	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	6.55e-06	0.000752	CbGpPWpGaD
Irinotecan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	6.54e-06	0.000751	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	6.53e-06	0.00075	CbGpPWpGaD
Irinotecan—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.51e-06	0.000175	CcSEcCtD
Irinotecan—UGT1A1—Metabolism—NME1—peripheral nervous system neoplasm	6.49e-06	0.000746	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—NME1—peripheral nervous system neoplasm	6.49e-06	0.000746	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.47e-06	0.000743	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GNS—peripheral nervous system neoplasm	6.36e-06	0.000731	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.36e-06	0.00073	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	6.35e-06	0.000729	CbGpPWpGaD
Irinotecan—Nausea—Epirubicin—peripheral nervous system neoplasm	6.32e-06	0.00017	CcSEcCtD
Irinotecan—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.26e-06	0.000168	CcSEcCtD
Irinotecan—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	6.26e-06	0.000719	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—COX2—peripheral nervous system neoplasm	6.25e-06	0.000718	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—COX2—peripheral nervous system neoplasm	6.25e-06	0.000718	CbGpPWpGaD
Irinotecan—Rash—Doxorubicin—peripheral nervous system neoplasm	6.21e-06	0.000167	CcSEcCtD
Irinotecan—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	6.2e-06	0.000713	CbGpPWpGaD
Irinotecan—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.2e-06	0.000167	CcSEcCtD
Irinotecan—Headache—Doxorubicin—peripheral nervous system neoplasm	6.17e-06	0.000166	CcSEcCtD
Irinotecan—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.12e-06	0.000703	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—NME1—peripheral nervous system neoplasm	6.1e-06	0.000701	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	6.02e-06	0.000692	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.99e-06	0.000688	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	5.95e-06	0.000683	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—COX2—peripheral nervous system neoplasm	5.87e-06	0.000675	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.87e-06	0.000674	CbGpPWpGaD
Irinotecan—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.85e-06	0.000157	CcSEcCtD
Irinotecan—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.82e-06	0.000669	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	5.74e-06	0.00066	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	5.72e-06	0.000658	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	5.69e-06	0.000654	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.69e-06	0.000654	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	5.6e-06	0.000643	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.54e-06	0.000636	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	5.51e-06	0.000633	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ENO2—peripheral nervous system neoplasm	5.49e-06	0.000631	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.47e-06	0.000629	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	5.46e-06	0.000627	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	5.45e-06	0.000626	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.44e-06	0.000625	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.37e-06	0.000617	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	5.3e-06	0.000609	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	5.25e-06	0.000604	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.2e-06	0.000598	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.11e-06	0.000587	CbGpPWpGaD
Irinotecan—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.9e-06	0.000563	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.82e-06	0.000554	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.82e-06	0.000553	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.73e-06	0.000543	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	4.72e-06	0.000542	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—BCHE—peripheral nervous system neoplasm	4.64e-06	0.000533	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	4.44e-06	0.00051	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.43e-06	0.000508	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—TH—peripheral nervous system neoplasm	4.36e-06	0.000501	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ENO2—peripheral nervous system neoplasm	4.32e-06	0.000497	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.29e-06	0.000493	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	4.24e-06	0.000487	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	4.21e-06	0.000484	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	4.14e-06	0.000476	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	4.11e-06	0.000473	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ENO2—peripheral nervous system neoplasm	4.1e-06	0.000471	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ENO2—peripheral nervous system neoplasm	4.1e-06	0.000471	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.07e-06	0.000468	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.07e-06	0.000467	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	4.04e-06	0.000464	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.96e-06	0.000455	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	3.95e-06	0.000454	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	3.94e-06	0.000453	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	3.93e-06	0.000451	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.92e-06	0.00045	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	3.88e-06	0.000446	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ENO2—peripheral nervous system neoplasm	3.86e-06	0.000443	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	3.81e-06	0.000437	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	3.8e-06	0.000436	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	3.76e-06	0.000432	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.69e-06	0.000425	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—BCHE—peripheral nervous system neoplasm	3.65e-06	0.00042	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	3.6e-06	0.000414	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GNAS—peripheral nervous system neoplasm	3.56e-06	0.000409	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GNS—peripheral nervous system neoplasm	3.54e-06	0.000407	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ABCB1—peripheral nervous system neoplasm	3.49e-06	0.000401	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.48e-06	0.0004	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	3.48e-06	0.0004	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—BCHE—peripheral nervous system neoplasm	3.46e-06	0.000398	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—BCHE—peripheral nervous system neoplasm	3.46e-06	0.000398	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	3.45e-06	0.000396	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	3.43e-06	0.000395	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—TH—peripheral nervous system neoplasm	3.43e-06	0.000394	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—HRAS—peripheral nervous system neoplasm	3.4e-06	0.000391	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NME1—peripheral nervous system neoplasm	3.4e-06	0.00039	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	3.34e-06	0.000384	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.31e-06	0.00038	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.31e-06	0.00038	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	3.27e-06	0.000376	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.27e-06	0.000376	CbGpPWpGaD
Irinotecan—ALB—Metabolism—COX2—peripheral nervous system neoplasm	3.27e-06	0.000376	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—TH—peripheral nervous system neoplasm	3.26e-06	0.000374	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—TH—peripheral nervous system neoplasm	3.26e-06	0.000374	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.24e-06	0.000372	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.19e-06	0.000366	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	3.17e-06	0.000365	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	3.14e-06	0.000361	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.11e-06	0.000357	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	3.1e-06	0.000357	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—TH—peripheral nervous system neoplasm	3.06e-06	0.000352	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—HRAS—peripheral nervous system neoplasm	3.04e-06	0.000349	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.03e-06	0.000348	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	2.98e-06	0.000343	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.98e-06	0.000342	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.97e-06	0.000342	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	2.94e-06	0.000338	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.92e-06	0.000335	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	2.91e-06	0.000335	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	2.87e-06	0.000329	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.8e-06	0.000322	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GNAS—peripheral nervous system neoplasm	2.8e-06	0.000322	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.78e-06	0.000319	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	2.76e-06	0.000318	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ABCB1—peripheral nervous system neoplasm	2.75e-06	0.000316	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	2.74e-06	0.000315	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GNAS—peripheral nervous system neoplasm	2.66e-06	0.000306	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GNAS—peripheral nervous system neoplasm	2.66e-06	0.000306	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.65e-06	0.000304	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.61e-06	0.0003	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ABCB1—peripheral nervous system neoplasm	2.61e-06	0.0003	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.6e-06	0.000299	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	2.56e-06	0.000295	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.55e-06	0.000293	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	2.55e-06	0.000293	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.52e-06	0.000289	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GNAS—peripheral nervous system neoplasm	2.5e-06	0.000287	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	2.49e-06	0.000286	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ABCB1—peripheral nervous system neoplasm	2.45e-06	0.000282	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	2.44e-06	0.00028	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.39e-06	0.000275	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.39e-06	0.000274	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	2.26e-06	0.000259	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	2.24e-06	0.000257	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.21e-06	0.000254	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	2.19e-06	0.000252	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	2.15e-06	0.000248	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	2.15e-06	0.000247	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	2.13e-06	0.000244	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	2.11e-06	0.000242	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.1e-06	0.000241	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.06e-06	0.000236	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	2.03e-06	0.000233	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.01e-06	0.000231	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	1.98e-06	0.000228	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.91e-06	0.00022	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.88e-06	0.000216	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.83e-06	0.000211	CbGpPWpGaD
Irinotecan—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	1.81e-06	0.000208	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.8e-06	0.000207	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.77e-06	0.000203	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.77e-06	0.000203	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.73e-06	0.000199	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TH—peripheral nervous system neoplasm	1.71e-06	0.000196	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	1.68e-06	0.000193	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	1.65e-06	0.00019	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.62e-06	0.000186	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	1.62e-06	0.000186	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.59e-06	0.000183	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	1.59e-06	0.000182	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.52e-06	0.000174	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.49e-06	0.000172	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	1.43e-06	0.000165	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	1.39e-06	0.00016	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	1.37e-06	0.000157	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	1.28e-06	0.000147	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.22e-06	0.00014	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—peripheral nervous system neoplasm	1.19e-06	0.000137	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.16e-06	0.000133	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	1.1e-06	0.000126	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	1.05e-06	0.000121	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	9.79e-07	0.000113	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—peripheral nervous system neoplasm	9.61e-07	0.00011	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	9.36e-07	0.000108	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.34e-07	0.000107	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	9.27e-07	0.000106	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	9.21e-07	0.000106	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	8.26e-07	9.5e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—peripheral nervous system neoplasm	7.56e-07	8.69e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	7.52e-07	8.64e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	7.38e-07	8.47e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—peripheral nervous system neoplasm	7.18e-07	8.25e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—peripheral nervous system neoplasm	7.18e-07	8.25e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	6.92e-07	7.95e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—peripheral nervous system neoplasm	6.75e-07	7.75e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	6.58e-07	7.56e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	6.09e-07	7e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	6.04e-07	6.94e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	4.46e-07	5.13e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	4.36e-07	5.01e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	3.76e-07	4.32e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	3.29e-07	3.78e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.03e-07	2.33e-05	CbGpPWpGaD
